Table 3. Factors associated with death in traditional peoples and communities with SARS due to COVID-19 in Brazil, 2020 to 2023.
| Variables | Bivariate logistic regression | Multivariate logistic regression* | ||||
|---|---|---|---|---|---|---|
| OR | IC95% | p-value | OR | IC95% | p-value | |
| Sexo | ||||||
| Sex | ref | – | – | ref | – | – |
| Female | 1,28 | 1,16−1,41 | <0,001 | 1,39 | 1,18− 1,63 | <0,001 |
| Male | ||||||
| Race/Color | ref | – | – | |||
| White | 1,89 | 1,35 −2,64 | <0,001 | 2,92 | 1,68− 5,08 | <0,001 |
| Black | 1,58 | 1,34 − 1,87 | <0,001 | 2,01 | 1,52− 2,67 | <0,001 |
| Brown | 1,39 | 1,21 − 1,61 | <0,001 | 2,25 | 1,73− 2,94 | <0,001 |
| Indigenous | 1,3 | 0,80 − 2,08 | 0,3 | 1,61 | 0,57− 4,24 | 0,3 |
| Asian | ||||||
| Age Group | ref | – | – | |||
| < 1 year | 1,32 | 0,74−2,40 | 0,30 | 0,77 | 0,17− 4,13 | 0,7 |
| 1 to 4 years | 0,97 | 0,54−1,77 | >0,9 | 0,3 | 0,05− 1,74 | 0,2 |
| 5 to 11 years | 0,76 | 0,39−1,46 | 0,40 | 0,76 | 0,19− 3,80 | 0,7 |
| 12 to 19 years | 1,8 | 1,16−2,93 | 0,012 | 2,41 | 0,79− 10,5 | 0,2 |
| 20 to 59 years | 4,67 | 3,01-7,59 | <0,001 | 6,57 | 2,16- 28,5 | 0,003 |
| 60 to 79 years | 7,77 | 4,95−12,70 | <0,001 | 12,8 | 4,18- 55,8 | <0,001 |
| 80 years or more | ||||||
| Education | ref | – | – | |||
| Higher education | 2,21 | 1,58, 3,14 | <0,001 | 1,32 | 0,89− 1,96 | 0,2 |
| No schooling | 1,52 | 1,09, 2,13 | 0,015 | 1,18 | 0,82− 1,71 | 0,4 |
| Primary (1st cycle) | 1,34 | 0,95, 1,92 | 0,10 | 1,16 | 0,80− 1,71 | 0,4 |
| Primary (2nd cycle) | 0,9 | 0,63, 1,30 | 0,6 | 0,91 | 0,62− 1,34 | 0,6 |
| Secondary | ||||||
| Area | ref | – | – | |||
| Urban | 1,12 | 1,00-1,24 | 0,043 | 0,84 | 0,70− 1,00 | 0,052 |
| Rural | 0,59 | 0,30−1,07 | 0,1 | 0,23 | 0,08− 0,55 | 0,002 |
| Periurban | ||||||
| Dyspnea | ref | – | – | |||
| No | 3,01 | 2,55−3,54 | <0.001 | 2,16 | 1,77− 2,65 | <0,001 |
| Yes | ||||||
| Oxygen Saturation | ref | – | – | |||
| Normal | 2,82 | 2,44−3,26 | <0.001 | 2,13 | 1,78− 2,55 | <0,001 |
| Low | ||||||
| Loss of Taste | ref | – | – | |||
| No | 0,7 | 0,58−0,83 | <0.001 | 0,62 | 0,51− 0,75 | <0,001 |
| Yes | ||||||
| Diabetes | ref | – | – | |||
| No | 1,24 | 1,06−1,45 | 0,008 | 1,32 | 1,09− 1,61 | 0,005 |
| Yes | ||||||
| Chronic Cardiovascular Disease | ref | – | – | |||
| Yes | 1,23 | 1,05−1,44 | 0,008 | 1,41 | 1,17 − 1,71 | <0,001 |
| Immunosuppression | ||||||
| No | ref | – | – | |||
| Yes | 1,81 | 1,20−2,75 | 0,004 | 2,14 | 1,23 − 3,79 | 0,007 |
| Chronic Kidney Disease | ||||||
| No | ref | – | – | |||
| Yes | 1,69 | 1,27−2,26 | <0.001 | 1,64 | 1,10−2,46 | 0,017 |
| Ventilatory Support | ||||||
| Not used | ref | – | – | |||
| Non-invasive | 2,21 | 1,88 − 2,60 | <0.001 | 2,65 | 2,18 − 3,23 | <0,001 |
| Invasive | 23,3 | 19,0 - 28,6 | <0.001 | 19,4 | 15,2 - 25,0 | <0,001 |
| ICU | ||||||
| No | ref | – | – | |||
| Yes | 5,33 | 4,74−6,00 | <0.001 | 2,15 | 1,85 − 2,49 | <0,001 |
CI: 95% Confidence Interval; OR: